XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheet Components (Tables)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Inventory Inventory consisted of the following (in thousands):
March 31, 2023December 31, 2022
Finished goods$3,247 $2,962 
Work in progress4,713 4,306 
Raw materials10,058 11,964 
Total inventory$18,018 $19,232 
Components of Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands):
March 31, 2023December 31, 2022
Clinical studies$13,883 $14,816 
Professional fees8,262 6,115 
Short-term lease liability5,738 5,591 
Deferred revenue5,841 5,342 
Deferred payments for intangible assets2,641 2,062 
Accrued royalty2,087 4,633 
Laboratory processing fees and materials 1,760 2,189 
License and other collaboration fees1,017 1,000 
Contingent consideration825 1,025 
Accrued shipping expenses459 489 
Capital expenditures— 1,316 
Other accrued expenses4,372 4,553 
Total accrued and other liabilities$46,885 $49,131